ArticleFrontiers in pediatrics2026
Fibrous hamartoma of infancy: a case report.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Fibrous hamartoma of infancy is a rare benign mesenchymal soft-tissue tumor characterized by a triphasic organoid architecture. Because its clinical and imaging features are variable, fibrous hamartoma of infancy may mimic inflammatory, vascular, benign fibro-fatty, intermediate, or malignant soft-tissue lesions. Case description: We report an approximately 6-month-old boy with a painless, progressively enlarging subcutaneous mass in the right axillary/medial upper-arm region. The lesion was initially interpreted as BCG-associated lymphadenitis; aspiration yielded no purulent material, and serial ultrasonography demonstrated progressive enlargement. Magnetic resonance imaging revealed a 67 × 40 × 58 mm well-circumscribed subcutaneous mass with marked contrast enhancement and no definite diffusion restriction or muscle invasion; infantile myofibroma and an intermediate soft-tissue lesion were considered. Complete gross excision was achieved while preserving the visualized muscle and neurovascular structures. Histopathologic examination demonstrated the characteristic triphasic pattern of fibrous hamartoma of infancy, and the immunohistochemical findings supported the diagnosis. Discussion: This case illustrates how sequential clinical assessment, multimodal imaging, operative findings, and histopathologic correlation can resolve a broad differential diagnosis in an infant with a rapidly enlarging soft-tissue mass. Conclusion: Fibrous hamartoma of infancy should be considered in infants with a painless, enlarging axillary or upper-extremity mass, particularly when imaging findings are nonspecific. Histopathologic confirmation is essential to establish the diagnosis and avoid unnecessarily aggressive oncologic treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.